secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOREGENX, INC. (BRGX)
CIK:        0001593184
Form:       8-K
Filed at:   2024-07-23T23:59:59+00:00
Accession:  0001683168-24-004996
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

BioRegenx officer and director Sherri Adams resigns effective July 17, 2024
---------------------------------------------------------------------------

- Sherri Adams resigned as officer and director effective July 17, 2024, to pursue other business interests.
- Departure was not due to any disagreement with the company, its board, or management.
- No replacement named; CEO William Resides signed the filing.
- Adams' role as officer/director leaves board with at least one vacancy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1593184/000168316824004996/0001683168-24-004996-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1593184/000168316824004996/bioregenx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-004996

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer